Tamsulosin Hydrochloride Capsule
Product Images NDC 0615-8055

8 FDA label images from Ncs Healthcare Of Ky, Llc Dba Vangard Labs · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 0615-8055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tamsulosin HCl Caps Aurobindo For Rising 1

Tamsulosin HCl Caps Aurobindo For Rising 1
Chemical structure diagram of tamsulosin hydrochloride showing its molecular arrangement including aromatic rings, functional groups, and hydrochloride component.*
FDA Label Image

Tamsulosin HCl Caps Aurobindo For Rising 2

Tamsulosin HCl Caps Aurobindo For Rising 2
A line graph depicting mean plasma tamsulosin hydrochloride concentrations (ng/mL) over time (hours) following a single 0.4 mg dose under fasted and fed conditions. The graph shows higher peak concentrations earlier in the fasted state compared to the fed state, with both concentrations declining over 36 hours.*
FDA Label Image

Tamsulosin HCl Caps Aurobindo For Rising 3

Tamsulosin HCl Caps Aurobindo For Rising 3
A line graph titled 'Figure 2A Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 1,' showing mean change on the y-axis and treatment duration in weeks on the x-axis. The graph compares three treatments: 0.8 mg dose, 0.4 mg dose of Tamsulosin Hydrochloride, and placebo, illustrating changes in symptom score over 13 weeks and last observation carried forward (LOCF).*
FDA Label Image

Tamsulosin HCl Caps Aurobindo For Rising 4

Tamsulosin HCl Caps Aurobindo For Rising 4
Line graph showing the mean change from baseline in total AUA symptom score over a 13-week treatment period. The x-axis represents treatment duration in weeks, and the y-axis shows mean change in symptom score. Three treatment groups are depicted: 0.8 mg dose (circles, solid line), 0.4 mg dose (triangles, dashed line), and placebo (squares, solid line). The graph includes sample sizes at various time points and shows greater symptom score reductions for active treatment groups compared to placebo.*
FDA Label Image

Tamsulosin HCl Caps Aurobindo For Rising 5

Tamsulosin HCl Caps Aurobindo For Rising 5
A line chart titled 'Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 1' showing the mean change in urine flow rate over a 13-week treatment duration and last observation carried forward (LOCF). Three treatments are compared: 0.8 mg, 0.4 mg, and placebo, with mean changes plotted at different weeks. The y-axis represents mean change in mL/sec, ranging from 0 to 3.0, and the x-axis represents treatment weeks from baseline to week 13.*
FDA Label Image

Tamsulosin HCl Caps Aurobindo For Rising 6

Tamsulosin HCl Caps Aurobindo For Rising 6
A line graph showing the mean increase in peak urine flow rate (mL/sec) over treatment duration in weeks for Study 2. The graph compares three treatments: 0.8 mg, 0.4 mg, and placebo, indicating changes in urine flow rate across multiple time points up to 13 weeks and a last observation carried forward (LOCF) measurement.*
FDA Label Image

Tamsulosin HCl Caps Aurobindo For Rising 7

Tamsulosin HCl Caps Aurobindo For Rising 7
Label for Tamsulosin Hydrochloride capsules USP 0.4 mg manufactured for Rising and packaged by Vangard Labs, Glasgow, KY. Lot number 8055 and expiration date fields are blank. The label includes storage instructions (store at 20°-25°C), dispensing warnings to protect the product from moisture, and is marked for institutional use only. The label also features multiple smaller barcode labels with the same product and lot information.*
FDA Label Image

Tamsulosin HCl Caps Aurobindo For Rising 8

Tamsulosin HCl Caps Aurobindo For Rising 8
Label sheet for Tamsulosin Hydrochloride 0.4 mg capsules shows multiple identical drug labels. Each label includes the drug name, strength, dosage form as capsules USP 0.4 mg, lot number placeholder, expiration date placeholder, and a barcode. The labels indicate packaging by Vangard, Glasgow, KY 42141. Additional text at the bottom references NDC 0615-8055-30 with storage instructions and Rx only status.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.